1. After being discharged a month ago, the patient’s condition has improved from a complete AIS A Spinal cord injury to an incomplete AIS B spinal cord injury.
2. Out of InVivo’s 11 INSPIRE patients, this patient now joins five others whose AIS grade has improved after discharge (54 percent).
3. Two additional patients remain in early follow-up stage, with conversion still possible in the coming months.
4. Biodegradable Neuro Spinal Scaffold implant allows neural regeneration to take place in wounded/traumatized regions.
5. InVivo was founded in 2005 with a goal to create and expand groundbreaking technologies and methods of care for SCI.
More articles related to the INSPIRE study:
INSPIRE study: University of New Mexico Hospital joins as 30th site
Rhode Island Hospital joins INSPIRE study as 29th clinical site: 5 points
Stryker, Mazor & more: 10 device company key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
